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Background: Understanding the physical activity experiences of patients with multiple myeloma (MM) is essential
to inform the development of evidence-based interventions and to quantify the benefits of physical activity. The
aim of this study was to gain an in-depth understanding of the physical activity experiences and perceived benefits
and barriers to physical activity for patients with MM.
Methods: This was a qualitative study that used a grounded theory approach. Semi-structured interviews were
conducted in Victoria, Australia by telephone from December 2011-February 2012 with patients who had been
treated for MM within the preceding 2–12 months. Interviews were transcribed and analysed using the constant
comparison coding method to reduce the data to themes. Gender differences and differences between treatment
groups were explored.
Results: Twenty-four interviews were completed. The sample comprised 13 females (54%), with a mean age of
62 years (SD = 8.8). Sixteen (67%) participants had received an autologous stem cell transplant (ASCT). All
participants currently engaged in a range of light to moderate intensity physical activity; walking and gardening
were the most common activities. Recovery from the symptoms of MM and side effects of therapy, psychological
benefits, social factors and enjoyment were important benefits of physical activity. Barriers to physical activity
predominately related to the symptoms of MM and side effects of therapy, including pain, fatigue, and fear of
infection. Low self- motivation was also a barrier. Women participated in a more diverse range of physical activities
than men and there were gender differences in preferred type of physical activity. Women were more likely to
report psychological and social benefits; whereas men reported physical activity as a way to keep busy and self-
motivation was a barrier. Patients treated with an ASCT more often reported affective benefits of participation in
physical activity and fatigue as a barrier. Patients treated with other therapies (e.g., chemotherapy, radiotherapy)
were more likely to report pain as a barrier.
Conclusions: Patients with MM experience debilitating effects of their condition and therapy, which influences
their level and intensity of physical activity participation. Physical activity programs should be individualised; take
into consideration gender differences and the impact of different types of therapy on physical activity; and focus
on meeting the psychological, coping and recovery needs of patients.
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Multiple myeloma (MM) is an incurable malignancy of
plasma cells. In 2010 in Australia, it was estimated that
1,400 people were diagnosed with MM, representing
1.2% of all cancer diagnoses. MM is more common in
men than women; the average age at diagnosis is 70 years
[1]. Although there is currently no cure for MM, modern
therapy can control the disease for prolonged periods and
the 5-year survival rates for MM have increased from
26% to 42% from 1985–1989 to 2005–2009 in Victoria,
Australia [2].
The preferred therapy for patients with MM depends
on their age, functional status and comorbidities. In
Australia, guidelines recommend that autologous stem
cell transplantation (ASCT) should be the standard of
care in patients up to 65–70 years following induction
therapy. This therapy comprises an induction regimen
incorporating novel agents (thalidomide, bortezomibor
or lenalidomide) designed to preserve the capacity to
harvest haematopoietic stem cells. Patients older than
65 years with poor performance status, or younger pa-
tients with comorbidities are not eligible for ASCT due to
increasing toxicity, regimens usually combine melphalan
and steroids with novel agents. Supportive therapy may
include the use of bisphosphonates and erythropoietin as
per updated guidelines [3].
The treatment regimens for MM are complex and de-
manding [3]. The impact of the underlying disease and
the side effects of treatment include chronic pain, fatigue,
nausea and vomiting, recurrent infections and anaemia
[4,5]. Patients also frequently suffer from osteoporosis
and osteolytic bone lesions, putting them at increased
risk of pathological fracture [6,7]. These outcomes re-
duce the quality of life of patients and are often asso-
ciated with increased incidence of depression, anxiety
and distress [4,5,8].
Physical activity has been shown, through randomised
controlled trials, to improve physical and psychological
outcomes among patients with solid tumours [9-11].
This has led to interest in how participation in physical
activity may be facilitated for cancer survivors [12-14].
Physical activity behaviors, and the factors that influence
these behaviors, vary by cancer diagnosis [15-17], patient
demographics [6,7,15], and stage in the cancer journey
[15,16]. Thus it is important to examine the barriers to
physical activity and benefits of participation in physical
activity for specific cancer groups, such as MM, and at a
defined stage in the illness trajectory.
Examination of the specific benefits of physical activity
for people with MM is a relatively new area of research,
but one that is gaining increasing attention as the preva-
lence of MM increases and lifestyle behaviors, such as
physical activity, are recognised as important factors in
overall patient outcomes [18-20]. Research to date, albeitlimited, has shown that physical activity is safe and feas-
ible before, during and following treatment for MM; can
alleviate some of the side effects of treatment, including
fatigue; and can enhance the quality of life of patients
[18,21,22]. Despite these promising findings, the patho-
physiology of MM and associated therapies may make
physical activity uptake and adherence a challenge for
this group. Participation in physical activity is lower for
people with MM than other cancer types [18,23]. In
addition, Coleman et al. reported a high exercise attri-
tion rate of 42% in MM patients who participated in a
randomised trial [22].
One way of increasing our understanding of physical
activity in the lives of people with MM is to examine
participation experiences and the perceived benefits of
and barriers to participation. This information is essential
to inform the development of evidence-based interven-
tions to encourage physical activity uptake and adherence
and to quantify the benefits of physical activity for this
group. The aim of this study was to gain new insights in
to the physical activity experiences, perceived benefits,
and barriers to participation for patients who were treated
for MM within the preceding 2–12 months. Due to lim-
ited research in this area and the exploratory nature of this
study, a qualitative approach that examined physical activ-
ity experiences within the context of the patient’s broader
life and from the patient’s perspective, was selected.
Methods
This study was approved by the Human Research Ethics
Committee at Deakin University.
Research participants
Male and female patients who completed treatment for
MM were interviewed for this study. Inclusion criteria
were people living in Victoria Australia, aged 18 years
and over; a diagnosis of symptomatic MM who had
completed therapy (chemotherapy, radiotherapy, induc-
tion therapy and/or transplant) 2-12 months prior; and
with the ability to speak English and complete English-
language versions of the patient-completed measures.
Procedure
A purposive sampling technique was used to select pa-
tients who were living in Victoria, Australia. The patient
database maintained by the Leukaemia Foundation of
Australia was used to identify potential participants. The
database was screened for patient names, cancer diagno-
sis, age and address details as well as approximate date(s)
of treatment for MM. Potential participants were sent a
cover letter and Participant Information and Consent
Form, which provided an overview of the study, eligibility
criteria, and an explanation of what participation in the
study would involve. If patients deemed themselves
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complete the consent form and return it. Once received,
the interviewer rang the patient to confirm that they met
the eligibility criteria and an interview time was arranged.
A self-administered questionnaire was mailed to par-
ticipants prior to the telephone interview. Participants
were asked to complete the questionnaire before com-
pleting the interview and could use it as a reference
point during the interview. On completion of the inter-
view, participants were asked to return the questionnaire
using a reply paid envelope.
Telephone interviews were conducted from December
2011-February 2012. The interviews were conducted by
a nurse counsellor with knowledge of MM and extensive
experience in conducting interviews with cancer pa-
tients. Interviews were conducted by telephone and were
recorded (with the permission of participants). Interviews
continued until saturation was reached. A summary of the
research findings was sent to the participants once the
study was completed.
Measures
The questionnaire completed prior to the interview
measured patient and clinical characteristics, including
date of birth, highest level of education, postcode, living
arrangements, treatment type and length of time since
treatment. Current and pre diagnosis physical activity
was measured using an adapted version of the Leisure
Time Exercise Questionnaire developed by Godin et al.
[24,25]. Participants recorded their average weekly phys-
ical activity prior to diagnosis (pre diagnosis physical
activity) and their average weekly physical activity in the
past month (current physical activity). The Leisure Time
Exercise Questionnaire assesses average frequency and
duration of light (e.g., easy walking), moderate (e.g., brisk
walking) and strenuous (e.g., running) physical activity.
It has been used in studies of cancer survivors [26,27]
and patients with MM [18].
A grounded theory approach was taken in this study
[28]. Interviews were semi-structured and follow up
questions and probes facilitated a deeper understanding of
the participants’ perceptions and experiences of physical
activity. The interview prompts focused on participation
in physical activity before, during and after treatment and
any perceived barriers and benefits of participation. The
interview was guided by a series of pre-determined
prompts, with flexibility in the order in which they were
covered to allow the interview to flow. Prompts included:
“Can you describe your participation in exercise before
during and after treatment?”; “What things stop or limit
your participation in exercise?”; and “What things motiv-
ate you to exercise?”
One interviewer conducted all of the interviews. Author
one briefed the interviewer about the aims and purpose ofthe interviews and listened to and gave feedback on
interviewing style. Regular meetings were held between
author one and the interviewer to discuss important
themes, the point at which saturation was reached and
any logistical issues.
Data analysis
Descriptive statistics were used to analyse the question-
naire data, including the demographic and clinical charac-
teristics and participation in physical activity.
In terms of qualitative data, the interviews were tran-
scribed verbatim and the accuracy of the transcripts was
verified, with 80% checked by the researchers against the
interview recordings. Data from the interviews were
analysed using the nVivo software package. Pseudonyms
were assigned to participants so that they could not be
identified.
The analysis process was inductive and coding was
used to reduce the data into meaningful themes [29]. The
coding procedures applied the “constant comparison”
method [30]. The constant comparison method utilises
three stages of coding. For the initial stage, a relevant
code was applied to ideas in the transcripts to develop
categories which captured the meaning of the idea [31].
Under the supervision of authors one and five, a re-
search assistant coded the data. As a way of validating
the codes, three interviews were independently coded
by author one to check the interpretations of the coder
and validate the themes. There was agreement between
both researchers as to the dominant themes and their
interpretation of the meaning from the ideas repre-
sented in the interviews.
The second stage of coding involved reducing codes
through grouping similar codes into broader, more
encompassing themes and comparing them to one an-
other and cross checking back to the original interview
text. In the final stage, categories were delimited to gain
parsimony and focus on the aims of the study [31]. At
this stage, comparisons were made based on gender and
type of therapy (ASCT or other therapies, including
chemotherapy, radiotherapy). Examination of different
therapy groups was important as treatment with or with-
out ASCT may influence the functional status of the
patient, which may have an impact on their physical
activity. During the coding processes, the authors and
interviewer met to discuss the themes that were emerging
from the interviews.
In the Results section, the gender, age and main treat-
ment type of participants are included in parentheses
following direct quotes. Only the main treatment type
has been included here; participants may also have been
treated with a range of induction and supportive therapies
including thalidomide and steroids (e.g., prednisolone and
zometa).
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Sample and clinical characteristics
Thirty-two patients responded to the initial mail out, of
which eight did not complete the interview due to ineli-
gibility (i.e. had not received therapy for MM in the past
2–12 months; n = 5), too unwell or emotionally dis-
tressed (n = 2), or lack of interest in completing inter-
view (n = 1). In total, 24 interviews were completed, 13
were female (54%). The age of the sample ranged from
48–78 years, with a mean age of 62 years (SD = 8.8; see
Table 1).
The majority of participants lived with either a part-
ner/spouse 16 (67%); or a partner/spouse and children
(own or partners) (n = 6; 25%). In terms of highest level
of education, 10 (42%) had a University degree or higher
and 8 (33%) had a certificate or diploma. There wereTable 1 Sample and clinical characteristics
n (%)
(N = 24)
Gender
Male 11 (46)
Female 13 (54)
Age
Mean (SD) 62 (8.8)
Living Arrangements
Partner/spouse 16 (67)
Partner/spouse and children 6 (25)
Alone 2 (8)
Highest Level of Education
University degree or higher 10 (42)
Certificate or diploma 8 (33)
Secondary school 5 (21)
Primary school 1 (4)
Region
Metropolitan area 11 (46)
Regional/rural area 13 (54)
Treatment
Autologous Stem Cell Transplant 16 (67)
Chemotherapy 6 (25)
Radiotherapy 5 (21)
Other (e.g., steroids, Thalidomide/Revlimid) 17 (71)
Time Since Treatment Completion
2-4 months ago 4 (17)
5-7 months ago 9 (37.5)
8-10 months 2 (8)
11-12 months 4 (17)
Over 12 months 1 (4)
Ongoing (e.g., thalidomide) 4 (17)more participants from regional/rural areas (n = 13, 54%)
than metropolitan areas (n = 11, 46%).
Two-thirds of participants had been treated with a
stem cell transplant (n = 16; 67%) and most participants
had completed treatment 5–7 months ago (n = 9; 37.5%),
followed by 2–4 months ago (n = 4; 17%) or 11-12
months (n = 4; 17%).
Current participation in physical activity and change from
Pre-diagnosis
Current type and intensity of physical activity
None of the participants had participated in vigorous in-
tensity physical activity on an average week in the past
month; 56.2% participated in some moderate intensity
physical activity (M = 84 minutes per week, SD = 104.9);
and 69.6% participated in some light intensity physical
activity (M = 85 minutes per week, SD = 85.9). Overall
26% of participants were meeting the recommended
guidelines of 150 minutes of moderate-vigorous intensity
physical activity per week.
Walking, followed by gardening were the most com-
mon physical activities. A range of other activities were
also discussed, including bike riding, yoga, swimming,
stretching, tennis, pilates, tai chi, table tennis and
strength training. Most of these activities were of light to
moderate intensity. Participants also spoke about trying
to increase their level of physical activity after their ther-
apy. For some, this meant increasing the length of time
they walked each day. Participants also spoke about their
level of physical activity varying depending on how they
were feeling, which was a function of their health and
motivation as well as external factors like the weather.
…Yeah, well I try to walk every day. I’ve never been
really a sporty person but I’ve always enjoyed walking
prior to my myeloma and all of that. I enjoy
gardening a lot. So as I say, I try to walk, I won’t say
every day but probably five out of seven days a week
and I’ll definitely go off for about 30 to 60 minutes,
depends on the day and the weather and how I’m
feeling, what sort of energy I’m at, that sort of level.
(‘Francisa’, Female, 54 years, treated with a stem cell
transplant)
Change from physical activity prior to diagnosis
Most participants in the interviews reported that the in-
tensity and/or frequency of physical activity had reduced
since their diagnosis. This was consistent with the ques-
tionnaire data which showed that participation in mod-
erate and vigorous physical activity had reduced. Prior to
diagnosis, 21.7% participated in vigorous physical activity
and the mean number of minutes per week was 32.6
minutes (compared to 0 minutes now); 60.9% had partic-
ipated in moderate physical activity and the mean
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pared to 56.2% and 84 minutes per week now). The per-
cent of participants who were currently participating in
light intensity physical activity was similar to prior to
diagnosis (69.6% compared to 65.2%) and average mi-
nutes were similar at 71.1 minutes (prior to diagnosis)
and 85 minutes per week now. Note that the pre-diagno-
sis moderate and light intensity physical activity minutes
per week were not included for one participant whose
response was invalid.
Some participants were not able to do any sort of
physical activity; while others continued with lighter
intensity or less frequent physical activity compared to
before their diagnosis, as illustrated in the following quote.
Yeah, look, I wouldn't be doing as intense exercise as I
was previously. I physically probably can't do it to the
same level that I had. So in terms of quantity it's
probably dropped off slightly but there hasn't been a
large difference there. It's probably more just the
intensity at which I do it. (‘Michael’, Male, 48 years,
treated with a stem cell transplant)
There were some participants who were back to or
close to their pre diagnosis level of physical activity and
two actually participated in more physical activity now.
Both men and women participated in walking, how-
ever there were gender differences in other types of
physical activity. Women participated in a wider range
of activities than men and were more likely to report
participating in aquatics, gym work, pilates, yoga and Tai
Chi. Men were more likely to report participation in
golf, gardening, bike riding and bowls.Perceived benefits of physical activity
Almost all respondents reported that physical activity
was beneficial to them. These benefits were reported as
predominantly related to their recovery from treatment
and coping with symptoms of MM as well as psycho-
logical benefits. Other benefits included physical im-
provements such as appearance, weight loss, enjoyment
and social interaction.Recovery from treatment/disease
Recovery was defined by participants in terms of physical
and psychological recovery and also getting back in to a
normal routine that they enjoyed prior to their diagnosis.
Physical recovery was focused on the prevention of de-
terioration in physical health and function. There was a
sense that physical activity facilitated participants to
regain a routine and normality after what, for many, was
a traumatic diagnosis and treatment regimen.I think it gives you a more positive outlook if anything.
You can get back to normality and you can do things
you know…..(‘Sophie’, Female, 57 years, treated with a
stem cell transplant)
Not all participants, however, saw the benefits of exer-
cise in their recovery because the symptoms that they
experienced were so extreme and constant that nothing
seemed to relieve them:
Well I'd like to think that it was helping. But it doesn't
seem to be - I just don’t seem to be able to do anything
that is helping it [pain in lower body]. …… It's
consistently there all the time, lesser or more,
depending on the time of day. The more I seem to
walk, the worse it gets. (‘Frank’, Male, 64, treated with
a stem cell transplant)Psychological health
Many participants spoke about the psychological bene-
fits of physical activity. This was more prevalent than
the discussion of physical health benefits. There were
several dimensions to the perceived psychological health
benefits, these included (1) cognitive improvements of
being more alert, keeping the mind healthy and fresh,
and improvements in concentration; and (2) affective
changes including feeling good, a sense of accomplish-
ment, helping emotionally, helping to cope with MM.
In terms of cognitive improvement:
Well I suppose it just keeps you going. Certainly my
job is very sedentary and I know that if I don't start
the day with some exercise it's harder to concentrate
and things like that…(‘Anne’, Female, 58 years, treated
with a stem cell transplant)
Affective changes that were bought on through phys-
ical activity, including feeling better and keeping the
mind from worrying are demonstrated through this
quote:
Oh. Put it this way, I was quite depressed when I was
in the house after the stem cells transplant and, of
course, after the two VAD chemo. I find myself if I go
out and did a bit of walking, I feel a little bit better, so
I go from there. (‘Jane’, Female, 60 years, treated with a
stem cell transplant)
Although the psychological benefits were noted among
both men and women, there were some differences.
Men reported being motivated to ‘do something’ and
keep busy, whereas women more often reported the
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better. Affective changes, particularly ‘feeling good’
were more often reported by those who had an ASCT
compared to other those who had other types of
therapy.
Enjoyment
Most of the participants said they enjoyed being physically
active; this was often intertwined with the psychological
benefits of participation and ‘feeling better’ and also the
sense of accomplishment that comes with being physically
active:
Oh I enjoy it actually - particularly a long walk - as I
said before 300 odd kilometres - when you finish a
walk like that you feel very - as if you've accomplished
something really good. (‘Andrew’, Male, 78 years,
treated with Thalidomide)
Social factors
Social factors were another motivation for physical activ-
ity. Although some participants enjoyed being physically
active and having time to themselves, others saw it as an
opportunity to be involved with family and friends. Phys-
ical activity was also seen as a way of connecting with
other people, avoiding isolation, getting back in to life after
MM and making new friendships. This could be with
people with MM or other friends. Both men and women
enjoyed the social aspects of participation; however this
was discussed more by women than men.
I'm always better to have done exercise in a group,
basketball, netball, all of that. The oncology rehab,
going there twice a week and the girls right now we'll
go for a walk, now we'll do this, now we'll do that. I
need someone to push me a little. (‘Tina’, Female,
65 years, treated with a stem cell transplant)
Perceived barriers to physical activity
MM symptoms and side effects of treatment
The most prevalent barriers to physical activity were
symptoms of MM and side effects of treatment. Barriers
either limited physical activity or stopped it completely.
These included fatigue (low energy levels, little stamina
and tiredness); pain (particularly bone pain); concerned
about bone fractures/bones; low immune system and
subsequent fear of infections in public exercise locations,
particularly gyms; taking medications in a timely manner;
self-conscious about appearance after treatment (weight
gain, loss of hair); anaemia; back pain; and foot weakness.
Fatigue, both physical and mental, was the most prom-
inent barrier. Participants also experienced effects on
concentration and keeping their mind focused on tasks,
and sometimes felt ‘unsure about what you are doing’.One participant described this as having a ‘tired head’.
Participants reported that fatigue was felt over their
entire body and they experienced extreme tiredness.
… I get tired. I’m ready for bed at 8:30, nine o’clock
every night, you know…as soon as the sun goes down
I’m ready for bed and I’ll go and jump into bed… So I
don’t know whether it’s the drugs or whether it’s the
myeloma. The physicians told me it’s probably mainly
the drugs that has done it. Hopefully the myeloma is
under control at the moment. (‘Charles’, Male,
51 years, treated with chemotherapy)
Pain was also a barrier that limited or prohibited phys-
ical activity. This pain was mostly related to bone pain
in various parts of the body, including the back, neck, el-
bows and hips. As pain levels were more debilitating on
some days than others, it had the effect of either limiting
or completely preventing any sort of physical activity. The
intensity and ongoing nature of the pain was wearing on
participants and made it difficult to continue on with their
day to day life.
… I’ve got pains in the back and look, I’m all right at
the moment, touch wood, but you know, pains in the
back and hip, one of my elbows and they’re just sort of
– I don’t know, it just grinds you down, I suppose, and
makes you come to a stop or in my case anyway.
(‘Charles’, Male, 51 years, treated with chemotherapy)
However, pain was not experienced as much by some
participants, who felt that it was not a barrier for them:
I'm lucky. I don’t feel that much pain related to the
myeloma, but if I'm really painful, well, I'll stop a day
or two and see how it goes. If it doesn't go away, I
know something's wrong, so I go to see my doctor.
(‘Jane’, Female, 60 years, treated with a stem cell
transplant)
Fatigue was more commonly reported by people who
had been treated with an ASCT; however pain as a barrier
to physical activity was more often reported by people
who had been treated with other types of therapy such as
chemotherapy and/or radiotherapy.
Low self motivation and lack of interest in physical activity
Low self motivation and interest in physical activity were
barriers identified by participants. Low self motivation
was identified by participants who may have had an
interest in being involved in physical activity, however
they experienced a general lack of motivation. This was
intertwined with finding it difficult to ‘get going’, particu-
larly in the morning. Males reported having low self
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ical activity was more related to lack of interest in physical
activity itself and therefore not participating.
…. two things that stop me probably doing a lot of
exercise. One is I probably wouldn't be interested in it
but the other one - I don’t have any problem with my
heart, I'm sure I could do a bit of jogging or running,
but it's no interest to me. (‘Dean’, Male, 65 years,
treated with a stem cell transplant)
Discussion
The purpose of this study was to explore the physical ac-
tivity experiences of people with MM and perceived bene-
fits and barriers to participation. Patients overwhelmingly
reported that physical activity was beneficial; the most
prominent benefits were in symptom control and recovery
from the side affects of MM therapy and the psychological
benefits of participation. The main barriers to physical
activity related to the symptoms of MM and side effects of
therapy and low self-motivation. There were some gender
differences in type of physical activity that participants
engaged in and benefits and barriers; and there were also
some differences in benefits and barriers according to type
of therapy.
Participation in physical activity decreased since prior to
diagnosis, confirming the findings of previous research
with MM patients [18,23] and other cancer survivors
[32,33]. Physical activity was of light to moderate intensity,
and walking was the most popular type of activity,
followed by gardening. These findings are similar to
population-based studies, which show that walking is the
most popular physical activity among older adults [34].
Walking was the most popular physical activity for both
men and women, however there were some differences
between men and women in physical activity participation.
For example, women participated in aquatics, gym work
and pilates, whereas men participated in golf, gardening
and bike riding. These are consistent with gender differ-
ences in physical activity participation in the general
population of adults and older adults [34,35].
One-quarter of participants were meeting the recom-
mended guidelines of 150 minutes of moderate-vigorous
intensity physical activity per week; this was similar to
previous studies of people with multiple myeloma [25,36].
This compares with 30-45% of other cancer survivor
groups who met the guidelines for sufficient levels of
physical activity [6,18,30]. Our findings reinforce that MM
may be more debilitating than some other types of cancer,
which represents additional challenges to performing
regular physical activity for people with MM.
None of the participants from this study engaged in
vigorous physical activity. We found that participating in
light to moderate intensity physical activity is likely to bethe most feasible for patients with MM who experience
a range of physical limitations that effect mobility, and
who are also at increased risk of bone fractures and
infections [6,7]. These findings suggest that patients with
MM may find it difficult to meet the American College
of Sports Medicine guidelines for cancer survivors,
which advise that cancer survivors avoid inactivity and
follow the age-appropriate guidelines for aerobic activity;
the accumulation of 150 minutes per week of moderate to
vigorous intensity physical activity. However, in recogni-
tion of the specific needs of some cancer groups, the panel
acknowledged that there should be some cancer site-
specific alterations for patients and caution was advised
for those at increased risk of fracture and infection [37].
In this study, the social context of the physical activity
was important for people with MM and social interactions
were important to the overall physical activity experience;
this was particularly so for women. This finding supports
the findings of previous research which demonstrates that
having an exercise role model or partner is positively asso-
ciated with physical activity participation for patients with
MM [38], as well as other cancer groups, including pros-
tate cancer survivors [39] and breast cancer survivors [40].
One of the main reported benefits of physical activity
was helping to overcome the impact of MM treatment
and symptoms. This might be a mechanism through
which physical activity contributes to quality of life and
psychological health, as previous research has demon-
strated the association between symptom distress, quality
of life and depression [41].
The psychological benefits of physical activity, including
cognitive, affective and coping with cancer were frequently
reported by interview participants in our study. These
psychological benefits are particularly important for
people with MM, as depression and low quality of life are
frequently reported [4,8]. Although no randomised con-
trolled trials have been conducted with patients with MM,
two recent meta analyses of studies of cancer survivors
(primarily breast cancer) concluded that physical activity
had a positive effect on psychological health [42,43]. How-
ever, other studies have shown no association between
physical activity and depression and anxiety for breast can-
cer survivors [10,44] or colorectal cancer survivors [45].
There is evidence that the intensity of physical activity
plays an important role in outcomes [46]. The effect of
level of intensity on quality of life and psychological
health outcomes is complex and there is debate about
the optimal intensity, particularly for psychological
health [47]. A cross-sectional study of patients with MM
by Jones et al. showed that during off treatment periods,
minutes of participation in moderate plus vigorous in-
tensity physical activity, was associated with overall qual-
ity of life and all components of quality of life except
physical wellbeing, as well as reductions in fatigue and
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physical activity at various intensity levels on psycho-
logical health and quality of life outcomes for patients
with MM is warranted.
Symptoms of MM and side effects of treatment, par-
ticularly fatigue and pain, were the predominant barriers
to physical activity. Evidence suggests that symptoms of
fatigue, sleep disturbances, pain and loss of appetite
were significantly worse for MM patients than those
with lymphoma [48]. Fatigue and pain have been identi-
fied as barriers to physical activity in other studies of
cancer survivors [27,49] and people with MM [23].
Research has shown that higher levels of fatigue are as-
sociated with lower levels of physical activity for patients
with MM [18]. However, a small randomised controlled
trial by Coleman et al. demonstrated that physical activ-
ity reduced fatigue for patients with MM [21]. We found
that the extent to which pain and fatigue were barriers
to participation differed by treatment type, with pain
experienced more by people who had been treated with
therapies including chemotherapy and/or radiotherapy
and fatigue experienced more by people who had a
ASCT. These associations and their impact on physical
activity experiences requires further investigation.
Lack of self-motivation was also a barrier in our study,
particularly for men and for those who were treated
with chemotherapy and/or radiotherapy. Lack of self-
motivation has also been identified in other studies of
cancer survivors [49].
The strengths of this study were the inclusion of
people with MM who were recently treated, which facili-
tated recall of physical activity prior to diagnosis and the
experience of treatment. The selection of participants
from a population-based database increased the possibil-
ity of gaining perspectives from people from a range of
backgrounds and localities.
Limitations of the study also need to be considered
when interpreting the findings. This study was cross sec-
tional and comprised a small sample size, involving youn-
ger patients (mean age = 62 years) than the population of
MM patients (mean age at diagnosis of 70 years [1]) and
findings can therefore not be generalized to the popula-
tion. Participants were at least somewhat physically
active; with voluntary participation, this self-selection
bias is difficult to avoid. Participants had difficulty
recalling their treatment regimen and we are not
able to verify the accuracy of patient treatment sta-
tus. The measure of pre-treatment level of physical
activity was retrospective, which increases the possi-
bility of recall error [50]. However, the main focus
of this study was on the participants’ description and
lived experience of physical activity. Given these lim-
itations, the findings of our study should be further
examined through a population-based quantitativestudy examining the determinants of physical activity
and potential outcomes such as improved quality of
life (particularly levels of fatigue and pain), anxiety
and depression.
Conclusions
Patients with MM predominantly participate in light to
moderate intensity physical activity; this may be at least
partly attributed to the side effects of their condition
and treatment. Physical activity programs should focus
on meeting the psychological and recovery needs of
patients, while being conscious of the limitations that
are faced by people with MM. An individualised pro-
gram design that considers gender and treatment related
differences is warranted. The involvement of specialists
who understand MM is important so that side effects
and cancer symptoms are taken in to account in the de-
sign of physical activity programs.
Endnotes
aParticipant pseudonyms have been used.
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